Skip to main content
The Journal of Physiology logoLink to The Journal of Physiology
. 2001 Dec 15;537(Pt 3):763–778. doi: 10.1111/j.1469-7793.2001.00763.x

Regulation of the calcium release channel from rabbit skeletal muscle by the nucleotides ATP, AMP, IMP and adenosine

Derek R Laver *, Gerlinde K E Lenz *, Graham D Lamb *
PMCID: PMC2279010  PMID: 11744753

Abstract

  1. Nucleotide activation of skeletal muscle ryanodine receptors (RyRs) was studied in planar lipid bilayers in order to understand RyR regulation in vivo under normal and fatigued conditions. With ‘resting’ calcium (100 nm cytoplasmic and 1 mm luminal), RyRs had an open probability (Po) of ∼0.01 in the absence of nucleotides and magnesium. ATP reversibly activated RyRs with Po at saturation (Pmax) ∼0.33 and Ka (concentration for half-maximal activation) ∼0.36 mm and with a Hill coefficient (nH) of ∼1.8 in RyRs when Pmax < 0.5 and ∼4 when Pmax > 0.5.

  2. AMP was a much weaker agonist (Pmax∼0.09) and adenosine was weaker still (Pmax∼0.01–0.02), whereas inosine monophosphate (IMP), the normal metabolic end product of ATP hydrolysis, produced no activation at all.

  3. Adenosine acted as a competitive antagonist that reversibly inhibited ATP- and AMP-activated RyRs with nH∼1 and Ki∼0.06 mm at [ATP] < 0.5 mm, increasing 4-fold for each 2-fold increase in [ATP] above 0.5 mm. This is explained by the binding of a single adenosine preventing the cooperative binding of two ATP or AMP molecules, with dissociation constants of 0.4, 0.45 and 0.06 mm for ATP, AMP and adenosine, respectively. Importantly, IMP (≤ 8 mm) had no inhibitory effect whatsoever on ATP-activated RyRs.

  4. Mean open (τo) and closed (τc) dwell-times were more closely related to Po than to the nucleotide species or individual RyRs. At Po < 0.2, RyR regulation occurred via changes in τc, whereas at higher Po this also occurred via changes in τo. The detailed properties of activation and competitive inhibition indicated complex channel behaviour that could be explained in terms of a model involving interactions between different subunits of the RyR homotetramer.

  5. The results also show how deleterious adenosine accumulation is to the function of RyRs in skeletal muscle and, by comparison with voltage sensor-controlled Ca2+ release, indicate that voltage sensor activation requires ATP binding to the RyR to be effective.


In vertebrate skeletal muscle, dihydropyridine receptors (DHPRs) in the transverse-tubular (T) system membrane act as voltage sensors, detecting depolarization of an action potential and opening adjacent ryanodine receptor (RyR)/Ca2+ release channels in the apposing sarcoplasmic reticulum (SR) membrane, thereby releasing Ca2+ into the cytoplasm and activating the contractile apparatus (Tanabe et al. 1990; Melzer et al. 1995). In contrast to cardiac muscle, the influx of extracellular Ca2+ through the DHPR is not necessary for initiating Ca2+ release, as the DHPR/voltage sensors directly activate the RyRs by some protein-protein interaction. Studies on isolated RyRs in lipid bilayers (Smith et al. 1986) and on ryanodine binding and Ca2+ release in SR vesicles (Meissner et al. 1986) have shown that millimolar levels of ATP potently activate the skeletal muscle RyR in the virtual absence of cytoplasmic Ca2+, and in conjunction with Ca2+ can cause almost full activation. By-products of ATP hydrolysis, such as ADP and AMP, are less effective agonists of skeletal muscle RyRs (Meissner, 1984) and evidently compete with ATP for its site(s) on the RyR (Rousseau et al. 1988). However, it is uncertain whether such ATP stimulation is important to voltage sensor activation of the RyRs.

The cytoplasm of resting muscle fibres contains approximately 6-8 mm ATP (Hood & Parent, 1991; Nagesser et al. 1992, 1993; Fitts, 1994). With vigorous or sustained exercise, phosphocreatine stores in the fibre become depleted and the [ATP] can decline to less than 1 mm (Karatzaferi et al. 2001) on average in the cytoplasm and possibly even lower in particular local areas if there is restricted diffusion and a relatively high rate of ATP utilisation, as may be the case near the RyRs (see Discussion). Under these conditions much of the ADP is hydrolysed to AMP, rather than being reconverted to ATP, and the AMP is normally deaminated to inosine monophosphate (IMP) by myoadenylate deaminase, such that the [IMP] increases in an almost equimolar manner with the decline in [ATP] (Nagesser et al. 1992; Allen et al. 1995; Sabina & Holmes, 1995). The role of these changes in muscle fatigue is not well understood. Muscle fatigue is a multi-faceted phenomenon to which many factors contribute (Fitts, 1994; Allen et al. 1995). The decline in force occurring with sustained exercise is produced by changes in the response of the contractile apparatus and eventually also by a decline in Ca2+ release from the SR (Allen et al. 1995). It has been reported that local depletion of ATP near the RyRs (with the concomitant build-up of metabolic products) may contribute to this reduced Ca2+ release (Westerblad & Allen, 1992; Owen et al. 1996; Allen et al. 1997; Duke & Steele, 1998; Blazev & Lamb, 1999a,b), though it was unclear whether this effect was mediated by a mechanism involving ATP hydrolysis (Allen et al. 1997) or was related to interference with ATP stimulation of the RyR (Owen et al. 1996; Duke & Steele, 1998; Blazev & Lamb, 1999a,b).

To further investigate this, we examined here the regulation of single skeletal muscle RyR channels by ATP, AMP, IMP and adenosine in the absence of Mg2+. (It was necessary to omit Mg2+ because it is a potent inhibitor of RyRs in the absence of voltage sensor stimulation, see Discussion.) Adenosine is known to inhibit caffeine-induced Ca2+ release in permeabilised fibres from frog muscle (Duke & Steele, 1998) and to inhibit both caffeine-induced and voltage sensor-controlled Ca2+ release in rat muscle fibres, with IMP having no noticeable effect (Blazev & Lamb, 1999b). We show here that the effects of ATP and its metabolites on voltage sensor release of Ca2+ are all well explained by their competitive effects directly on the RyR. This provides strong evidence that (a) voltage sensor activation of the RyR requires concurrent stimulation of the RyR by cytoplasmic ATP and (b) that competition between ATP and its metabolites for the stimulatory binding sites on the RyR could well be responsible for reduced Ca2+ release in fatigue in normal individuals and for the early onset of fatigue in individuals with myoadenylate deaminase deficiency (MDD), where AMP cannot be deaminated to IMP and there are increased levels of adenosine (Sabina et al. 1984). Finally, this study describes and models findings that suggest that potent activation of the RyR occurs by simultaneous activation of its four subunits. A brief, preliminary report of some of these findings has been published previously (Laver et al. 2000a).

METHODS

Preparation of SR microsomes

SR vesicles were prepared from the back and leg muscles of New Zealand White rabbits killed by captive bolt prior to muscle removal. The procedure was carried out by the holder of a current licence granted under ACT State legislation. Native SR vesicles were isolated using techniques based on those of Chu et al. (1988) as previously described in Laver et al. (1995). Briefly, the muscle was differentially centrifuged to yield a crude microsomal fraction, which was fractionated by loading it onto a discontinuous sucrose gradient. Heavy SR vesicles were collected from the 35-45 % (w/v) interface, centrifuged, resuspended in buffer then snap frozen and stored in liquid N2 or at -70 °C.

Lipid bilayers, chemicals and solutions

Lipid bilayers were formed from phosphatidylethanolamine and phosphatidylcholine (4:1) (Avanti Polar Lipids, AL, USA) in n-decane, across an aperture of ∼200 μm diameter in a Delrin cup (Cadillac Plastics, NC, USA). The bilayer separated two solutions: cis and trans (∼1 ml). Vesicles were added to the cis solution and incorporation with the bilayer occurred as described by Miller & Racker (1976). Due to the orientation of RyRs in the SR vesicles, RyRs added to the cis chamber incorporated into the bilayer with the cytoplasmic face of the channel orientated to the cis solution. During SR vesicle incorporation the cis (cytoplasmic) solution contained 250 mm Cs+ (230 mm CsCH3O3S, 20 mm CsCl) with 1 mm CaCl2 and the trans (luminal) solution contained 50 mm Cs+ (30 mm CsCH3O3S, 20 mm CsCl), 1 mm CaCl2. The caesium salts were obtained from the Aldrich Chemical Company and CaCl2 from BDH Chemicals. The osmotic gradient across the membrane and the Ca2+ in the cis solution helped vesicle fusion with the bilayer. During measurements the cis solution contained 250 mm Cs+ (230 mm CsCH3O3S, 20 CsCl) with 100 nm Ca2+ (4.5 mm BAPTA, obtained as a tetra-potassium salt from Molecular Probes, 1 mm CaCl2) and various nucleotide concentrations at pH 7.4. The trans solution was the same as that used during vesicle incorporation. All solutions were pH buffered with 10 mm Tes (ICN Biomedicals) and solutions were titrated to pH 7.4 using CsOH (optical grade from ICN Biomedicals). The free [Ca2+] was estimated using published association constants (Marks & Maxfield, 1991) and the program ‘Bound and Determined’ (Brooks & Storey, 1992). ATP, AMP, IMP and adenosine were obtained in the form of sodium salts from Sigma Chemicals.

Solution changes

During experiments the composition of the cis solution was altered either by addition of aliquots of stock solutions or by perfusion of the bath near the bilayer. The local perfusion method allowed solution exchange between sixteen available solutions in random sequence. Details of the perfusion method are given by Laver et al. (2000b).

Data acquisition and analysis

Bilayer potential was controlled and currents recorded using either an Axopatch 200B amplifier (Axon Instruments) or a Bilayer Clamp-525C (Warner Instruments). The cis chamber was electrically grounded to prevent electrical interference from the perfusion tubes and the potential of the trans chamber was varied. However, all electrical potentials are expressed here using standard physiological convention (i.e. cytoplasmic side relative to the luminal side at virtual ground).

Unless otherwise stated, single channel recordings were obtained using a bilayer potential difference of +40 mV. RyRs with open probabilities in excess of ∼0.2 exhibit voltage-dependent inactivation (see Laver & Lamb, 1998) that depends on Po rather than on the specific channel activator. The occurrence of inactivation was minimised by application of brief (∼1 s) voltage steps to -40 mV at ∼15 s intervals.

During the experiments, the bilayer current was recorded after low pass filtering at 5 kHz, sampled at 50 kHz and simultaneously stored on computer disk using data interfaces (DT301 or DT3001, Data Translation, MA, USA) under the control of in-house software written in Visual Basic. For measurements of unitary current, Po and dwell times, the current signal was digitally filtered at 1 kHz with a Gaussian filter and sampled at 5 kHz. Unitary current and time-averaged currents were measured using Channel2 software (Professor P. W. Gage and Mr M. Smith at the Australian National University). To calculate Po from single channel records, a threshold discriminator was set at 50 % of channel amplitude to detect channel opening and closing events. For experiments in which bilayers contained several strongly activated RyRs, the time-averaged current was divided by the unitary current and the number of channels. This method of calculating Po gives a similar result to that obtained when measuring Po of single channels using a threshold discriminator (Laver et al. 1997a). Frequency histograms of dwell-time duration were compiled from channel records varying in duration from 30 to 120 s. Event durations were extracted from the data using 50 % threshold detection which, in conjunction with the filtering, had a dead-time of ∼200 μs. The histograms are presented as probability distributions using variable bin widths with equal separation on a log scale as described by Sigworth & Sine (1987).

The activation of RyRs by the nucleotides ATP and AMP was characterised by fitting (by least squares) a Hill equation (eqn (1)) to the relation between Po and nucleotide concentration:

graphic file with name tjp0537-0763-m1.jpg (1)

where nH is the Hill coefficient, Ka is the concentration of half-activation and Pmax is the open probability at maximum activation. Fitting was usually carried out using the pooled results from normalised data of several experiments (the averaged data points presented in the figures were not used for fitting). Ka was determined from data that were normalised for Pmax while nH was determined from data that were normalised for both Pmax and Ka. Inhibition of RyRs by adenosine was characterised by fitting an alternative form of the Hill equation (eqn (2)) to the relation between Po and adenosine concentration:

graphic file with name tjp0537-0763-m2.jpg (2)

where Pmax is the open probability of the uninhibited channel and Ki is the concentration for half-inhibition.

Unless otherwise stated the data are presented as means ± standard error of the mean (s.e.m.). The quality of fit parameter used was the root mean square of the residuals.

RESULTS

Activation of RyRs by nucleotides

The open probability of RyRs responded to changes in nucleotide concentration within the time expected for solution change at the bilayer surface (∼10 s). The open probability was determined from recordings of steady RyR activity lasting 30-120 s under each experimental condition. The response of individual RyRs to cytoplasmic nucleotides is shown in Fig. 1 and 2. The mean activation of RyRs by ATP and AMP is shown in Fig. 3A. The activating effects of different nucleotides were investigated on different groups of channels which, on average, showed slightly different levels of activity in the absence of nucleotides. In the absence of nucleotides, RyRs were relatively inactive at 100 nm cytoplasmic Ca2+ with an overall Po of 0.02 ± 0.02. Addition of ATP up to a concentration of 8 mm strongly activated RyRs to a Pmax of 0.33 ± 0.04, whereas AMP (up to 10 mm) was a less potent activator, giving rise to a mean Pmax of 0.09 ± 0.02. Adenosine (5-10 mm) produced only a slight activation of RyRs (2.1 ± 0.7-fold change by paired analysis, with Pmax= 0.008 ± 0.001) and IMP (up to 8 mm) produced no activation at all (0.9 ± 0.15-fold change by paired analysis, Pmax= 0.0012). Since the absolute values of Po in the adenosine and IMP experiments were extremely low (Po < 0.01) we endeavoured to obtain higher precision measurements of the IMP and adenosine effects by examining RyRs activated by 100 μm Ca2+, where Po= 0.28 ± 0.08 (n = 8) prior to nucleotide activation. RyRs in the presence of 5 mm IMP and 100 μm Ca2+ had a Pmax= 0.24, which was 85 ± 13 % (n = 4) of that in the absence of IMP. Similar analysis of adenosine activation showed that 5 mm adenosine, in the presence of 100 μm Ca2+, increased Pmax on average to 0.52, which represents an increase of 130 ± 30 % (n = 4). Thus, adenosine is a much weaker RyR agonist than ATP and AMP, and IMP has no discernible effect at all.

Figure 1. Representative segments of an experiment showing the competitive effects of ATP and adenosine on a single skeletal RyR.

Figure 1

The cis (cytoplasmic) solution contained 250 mm Cs+ (230 mm CsCH3O3S, 20 mm CsCl) with 100 nm Ca2+ (4.5 mm BAPTA, 1 mm Ca2+) and various concentrations of ATP and adenosine at pH 7. 4. The trans (luminal) solution contained 50 mm Cs+ (30 mm CsCH3O3S, 20 mm CsCl), 1 mm CaCl2 at pH 7. 4. All solutions were pH buffered with 10 mm Tes. The membrane potential was held at +40 mV and channel openings are shown here by upward deflections of the current from the baseline. The RyR open probability (Po) determined from > 30 s recordings is shown at the right of each trace. Top trace, RyRs were relatively inactive in 100 nm Ca2+ in the absence of ATP. Second trace, addition of 500 μm ATP to the cis bath (aliquot addition) markedly activated the channel. Traces 3-5, subsequent addition of adenosine reduced channel activity. Bottom trace, subsequently increasing [ATP] to 2000 μm reversed the inhibitory effect of 1000 μm adenosine.

Figure 2. Reversibility of ATP activation and adenosine inhibition of RyRs.

Figure 2

The experimental conditions are given in the legend to Fig. 1 and the nucleotide concentrations are given at the left of each trace. The Po, determined from > 30 s recordings, is shown at the right of each trace. Top trace, RyRs were found to be inactive in 100 nm Ca2+ in the absence of ATP (control solution) at the start of the experiment. Trace 2, addition of 4 mm ATP to the cis bath (local perfusion) activated the channel. Traces 3-6, after 8 min the channel activation by ATP could be completely reversed by flowing the control solution onto the channel. In the same experiment, solutions containing 4 mm ATP plus adenosine reversibly inhibited channel activity. Note the higher concentrations of adenosine used compared to Fig. 1.

Figure 3. The response of RyR Po to ATP and AMP.

Figure 3

Experimental conditions are given in Fig. 1. A, the average response of RyR Po to ATP and AMP. The data points show the means and s.e.m. of RyRs when exposed to cis ATP (•, n = 32) or to cis AMP (○, n = 19). The continuous curves show Hill curves (eqn (1)) fitted to the data. For ATP the fit parameters are Pmax= 0.33 ± 0.04, Ka= 0.48 ± 0.17, nH= 1.1 ± 0.7 and for AMP Pmax= 0.09 ± 0.02, Ka= 1.4 ± 0.3, nH= 1.9 ± 0.5. The inset shows the same data plotted with a linear abscissa. B, examples of the response to ATP of individual RyRs spanning the full range of observed Pmax.

Maximal activation achieved with either ATP or AMP showed considerable variation between individual channels (e.g. Fig. 3B). In the presence of 100 nm Ca2+ and 4-8 mm AMP or 1-8 mm ATP, RyRs reach near-maximal activation for that nucleotide, with Po being within 20 % of the respective Pmax. The frequency distributions of Pmax in Fig. 4 suggest continuous unimodal distributions that are skewed to low values. Thus, the Pmax distributions gave no indication that there were two or more distinct populations of RyRs present in these experiments. We also measured RyR activation by ATP in the presence of 1 nm Ca2+ to test the possibility that variations in Pmax in 100 nm Ca2+ reflected variations in RyR sensitivity to cytoplasmic Ca2+. In 1 nm Ca2+ the frequency distribution of Pmax was similar to that seen in 100 nm Ca2+. The Wilcoxon-Mann-Whitney test showed that there was no significant difference between the distributions (P = 0.5) indicating that variations in Pmax were not related to activation by cytoplasmic Ca2+.

Figure 4. Frequency distribution of maximum open probability (Pmax) of RyRs activated by ATP and AMP, showing the considerable variation between individual channels.

Figure 4

RyR activity was measured under experimental conditions given in Fig. 1 at cytoplasmic Ca2+ and nucleotide concentrations indicated. Over these ranges of [ATP] and [AMP] RyRs were near-maximally activated so that Po values approximate the Pmax for that RyR and nucleotide (see eqn (1)).

The dose-response of RyRs to ATP was examined by least squares fitting of the Hill equation, eqn (1), to the concentration dependencies of Po shown in Fig. 3. The average dose-response of RyRs to ATP (Fig. 3A) gave values of Pmax= 0.33 ± 0.04, Ka= 0.48 ± 0.17 mm and nH= 1.1 ± 0.7 (These values of Ka and nH from fits to the non-normalised, averaged data are not as accurate as those found when fitting to normalised data as done below, in particular causing nH to be underestimated - see Discussion on this point in Laver et al. 2000b). Since the variation in Pmax was relatively large, we separately pooled RyRs with high Pmax (> 0.5) from those with low Pmax (Pmax < 0.2) and intermediate Pmax (Pmax= 0.2-0.5) in order to test for possible correlations between Pmax and Ka and nH. Values of Ka obtained from data normalised for Pmax did not significantly differ between the three RyR groups (see Table 1) and had a weighted mean value of 0.36 mm. In order to get accurate values of the Hill coefficient, Hill fits were made to dose-responses that had been normalised to both Pmax and Ka for each RyR individually. RyRs in the lower activity groups had Hill coefficients for ATP activation of approximately 2 (Table 1) and RyRs with Pmax > 0.5 gave values of nH∼4.

Table 1.

Summary of Hill parameters obtained from fits of eqn (1) to the [nucleotide] dependencies of RyR Po

RyR activation Pmax Ka (mM) nH
ATP
Pmax= 0.5–0.9, n = 4 0.54 ± 0.05 0.35 ± 0.08* 3.8 ± 1.3
ATP
Pmax= 0.2–0.5, n = 5 0.33 ± 0.02 0.48 ± 0.08* 1.7 ± 0.5
ATP
Pmax= 0–0.2, n = 9 0.07 ± 0.02 0.29 ± 0.04* 1.8 ± 0.7
AMP
Pmax= 0–0.4, n = 19 0.09 ± 0.02 1.4 ± 0.3 1.9 ± 0.5

Pmax is the saturating level of Po, Ka is the nucleotide concentration that produces 50 % activation and nH is the Hill coefficient.

*

Ka values were determined from least squares fit to Po data that were normalised to 8 mM ATP.

nH values were determined from data in which Po was normalised to 8 mM ATP and [ATP] was normalised to Ka.

Values were obtained from data that were normalised to 5 mM AMP.

AMP activated RyRs at concentrations up to 10 mm, but to a lesser extent than did ATP. Maximal activation commonly occurred at 5 mm AMP and, at concentrations above this, RyR activity decreased in a similar way to that reported previously for cardiac RyRs (Ching et al. 1999). In 6 out of 10 experiments RyR activity decreased by 50 -80 % in the presence of 5-10 mm AMP, while in four others channel activity increased by 10-30 % over this concentration range. The average [AMP]-dependent activation of all 10 RyRs is shown in Fig. 3A. The inactivation at high [AMP] made it difficult to obtain a reliable estimate of Ka and nH from a Hill fit to the AMP data in Fig. 3. Therefore we determined Ka to be 1.4 mm from the [AMP] at which Po was 50 % of that at 5 mm AMP.

We also analysed AMP activation of RyRs in high- and low-activity groups using an arbitrary threshold of Pmax= 0.04 to define the two groups. The two groups gave identical values of Ka= 1.4 mm indicating that Ka for the AMP-activated RyRs did not depend on Pmax over the range 0 to 0.4. In summary, the average AMP data in Fig. 3A had values of Pmax= 0.09 ± 0.02, Ka= 1.4 ± 0.3, nH= 1.9 ± 0.5.

Effects of adenosine and IMP on RyRs activated by ATP or AMP

Adenosine inhibited the activity of RyRs activated by either ATP or AMP. This inhibition could be partially reversed by increasing the concentration of ATP or AMP. This is shown for the case of adenosine and ATP in Fig. 1. Thus, it appears that adenosine acts by competing with ATP and AMP for a common set of binding sites on the RyR. The adenosine inhibition dose-response curves of RyRs activated by 0.2-8 mm ATP are shown in Fig. 5A. Hill fits (eqn (2)) to these data show inhibition, with Hill coefficients ranging from 0.9 to 1.2 (Table 2) and a half-inhibiting [adenosine] (Ki) with biphasic dependence on [ATP] (see Fig. 5B). Over the range 0.2-0.5 mm, ATP had little effect on Ki (∼0.06 mm), whereas at higher [ATP], Ki increased ∼4-fold for each 2-fold increase in [ATP]. We found no significant difference between Ki values obtained from channels with high and low activity over the full range of [ATP] used in these experiments. Analysis of the competition between these nucleotides (see Discussion) indicates dissociation constants for adenosine, ATP and AMP of 0.06, 0.4 and 0.45 mm, respectively. This estimate of the dissociation constant for ATP is similar to the Ka for ATP activation (0.36 mm), whereas the dissociation constant for AMP is significantly lower than the Ka found when activating with AMP (1.4 mm, see earlier). The effect of IMP on ATP-activated RyRs was markedly different from that of adenosine. At concentrations up to 8 mm, IMP produced no inhibitory effect on RyRs that were activated by either 0.5 or 2 mm ATP (Fig. 6).

Figure 5. The inhibitory effect of adenosine in the presence of various concentrations of ATP and AMP.

Figure 5

A, pooled data showing the inhibitory dose-response behaviour of RyRs to adenosine in the presence of ATP at the following concentrations (mm): 0.2 (○, n = 5), 0.25 (▴, n = 5), 0.5 (▪, n = 14), 1 (▵, n = 5), 2 (•, n = 9), 4 (□, n = 9) and 8 (♦, n = 3). Channel activity is given as the mean and s.e.m. of open probability normalised in each experiment to that in the absence of adenosine. B, the half-inhibitory concentration of adenosine (Ki) in the presence of various concentrations of ATP (•) and AMP (○). Means and s.e.m. of Ki were determined from least squares fits of the individual adenosine dose-response data combined from all experiments under each experimental condition. Ki shows biphasic dependence on [ATP]. Over the range 0.2-0.5 mm, ATP has little effect on Ki whereas at higher [ATP], Ki increases ∼4-fold for each 2-fold increase in [ATP]. Ki for adenosine was similar in the presence of either ATP or AMP. The curves in A and B show model fits to the ATP data (continuous lines) and the AMP data (dotted line) based on Scheme 2. The values for the parameters of Scheme 2 are: KATP= KATP2= 0.4 mm, KAMP= KAMP2= 0.45 mm, Kad= Kad2= 0.06 mm.

Table 2.

Summary of the parameters obtained from fitting eqn (2) to the adenosine inhibition data (see Fig. 5)

Ki for adenosine (mM) nH n
[ATP] (mM)
 0.2 0.066 ± 0.022 0.9 ± 0.3 5
  0.25 0.093 ± 0.04 0.6 ± 0.5 5
 0.5 0.076 ±. 017 1.0 ± 0.3 14
1 0.33 ± 0.08 1.2 ± 0.6 5
2 2.0 ± 0.3 1.2 ± 0.4 9
4 5.6 ± 1.2 0.9 ± 0.4 9
8 20 ± 10 2
[AMP] (mM)
1 0.43 ± 0.12 1.5 ± 0.7 7
4 4.0 ± 1.5 1.2 ± 0.8 5

Ki is the [adenosine] that produces 50 % inhibition, nH is the Hill coefficient and n is the number of RyRs observed.

Figure 6. Pooled data showing that cis IMP has no significant effect on the activity of RyRs activated by either 0.5 mm ATP (•, n = 5) or 2 mm ATP (○, n = 4).

Figure 6

Experimental conditions are given in Fig. 1. Channel activity is shown by the mean and s.e.m. of Po normalised in each experiment to that in the absence of IMP.

Reversibility of nucleotide effects

The effects of ATP and adenosine were reversible in most cases (Fig. 2). In 18 experiments, RyR activity was measured under control conditions (∼100 nm Ca2+ in the absence of nucleotides) both at the beginning of each experiment and after several minutes exposure to ATP. In 15 of these experiments RyR activity returned to low levels upon washout after 5-18 min exposure to ATP. In the remaining three experiments RyRs showed greater activity (Po > 0.05) under control conditions after 5, 12 and 18 min exposure to ATP than at the start of the experiments (Po= 0.005). In these cases ATP, adenosine and Ca2+ also failed to regulate RyR activity. In the last of these three experiments, six RyRs had incorporated into the bilayer but only one channel showed irreversible behaviour. Thus, after more than 5 min exposure to ATP, ∼15 % of RyRs appeared to be activated by unknown factors other than the presence of nucleotides and were not included in the present analysis. Due to premature ruptures of the lipid bilayer, we were unable to test for reversibility of ATP activation in half of our experiments. However, in these experiments the exposures of RyRs to ATP were generally of less than 5 min duration, so that it was unlikely that these RyRs were not regulated by nucleotides in the normal manner.

Analysis of dwell times

Information about the mechanisms of nucleotide regulation of RyRs can be gained from analysis of dwell times, beginning here with mean closed and open dwell times (τc and τo, respectively) and then following with a more detailed analysis of dwell time distributions. Activation of RyRs by ATP occurred via a decrease in τc (Fig. 7B). In channels that were activated to Po > 0.2, activation was also associated with an increase in τo (Fig. 7A). These dependencies of τo and τc on Po are shown in Fig. 7C and D. The same behaviour was also found for AMP-activated RyRs, as well as those inhibited by adenosine (see below).

Figure 7. Effect of nucleotides on the mean open and closed dwell times of RyRs.

Figure 7

A and B, effect of ATP concentration on the mean open (τo, A) and closed (τc, B) dwell times of representative RyRs. Pmax values shown here cover the full range of activating levels induced by ATP. Pmax values obtained for each RyR are as follows: ▴, -0.96; •, -0.64; ▪, -0.6; ⋄, -0.12; ▵, -0.11; ○, -0.02. C and D, summaries of all mean open (τo, C) and closed (τc, D) dwell times data, showing the effect of ATP (0-8 mm, ▴) and AMP (0-5 mm, □) activation and adenosine (0-10 mm, ○) inhibition of RyRs. Here, dwell times are plotted against the degree of channel activation (Po) rather than nucleotide concentration. In all cases, nucleotide regulation of Po was associated with changes in mean closed dwell times. However, when Po exceeded ∼0.2, nucleotides had a relatively strong effect on the mean open dwell times. The dashed line in C shows the duration of the shortest detectable gating events.

Since two or more ATP molecules are evidently involved in RyR activation (see nH for nucleotide activation and the [ATP] dependence of Ki for adenosine inhibition), we analysed the [ATP] dependence of τc in order to estimate the number of ATP molecules that must bind to the closed channel before it can open. These data were fitted with eqn (3), in which N represents the number of ATP molecules needed to open the channel, K is the average dissociation constant for the ATP molecules and τc,max and τc,min are the mean closed times in the absence of ATP and at maximal ATP activation, respectively:

graphic file with name tjp0537-0763-m3.jpg (3)

This analysis of the data gave values of N = 2.0 ± 0.2 (n = 8), which indicates that the binding of at least two ATP molecules is required to open RyRs. Values of N did not show any significant dependency on Pmax. The N values for high activity RyRs (N = 2.0 ± 0.5, n = 3, Pmax > 0.5) were similar to those for low activity RyRs (N = 1.9 ± 0.3, n = 5, Pmax < 0.2). ATP clearly had an effect on τo under some circumstances (see above), which indicates that ATP also interacts with the RyR in its open state. The ATP-dependent increase in τo was usually quite abrupt, the full increase occurring between sampled ATP concentrations. Consequently we were unable to obtain reliable estimates of N from a similar analysis to that used for τc. However, the abrupt increase in τo indicated N > 2.

The effect of adenosine inhibition on τo and τc of ATP-activated RyRs is shown in Fig. 8. Adenosine inhibition had a similar effect to that of a decrease in the activating nucleotide concentration, in that in all cases adenosine increased τc but only produced a decrease in τo when τo had increased with ATP- or AMP-induced activation (see Fig. 7C).

Figure 8. Effects of adenosine inhibition on the mean open (τo, A) and closed (τc, B) dwell times of four representative RyRs.

Figure 8

Adenosine inhibition was produced in the presence of 0.5 mm ATP and is shown here for two RyRs that were strongly activated by ATP (•, Pmax= 0.64; ▪, Pmax= 0.67) and for another two that were weakly activated by ATP (○, Pmax= 0.03; □, Pmax= 0.06). In all cases adenosine increased the mean closed dwell times but only decreased the open dwell times of RyRs that had been strongly activated by ATP.

ATP activation and adenosine inhibition mechanisms were investigated in more detail by analysing the open and closed dwell-time distributions. These were compiled from 10 channels, five of which could be activated to medium and high levels by ATP (Po > 0.2) and five of which could only be activated to lower levels. Open dwell-time distributions obtained from low activity, ATP-activated channels had two exponential time constants of 0.7 and 2.5 ms (see Table 3 and also Fig. 9D). These open time distributions did not depend on either the ATP or adenosine concentration. This is in contrast to the ATP dependence seen in the dwell times of RyRs that could be activated to medium or high activity. These RyRs, while at relatively low levels of nucleotide activation (i.e. at low [ATP] where Po < 0.1), also exhibited two time constants (0.9 ± 0.1 and 4.0 ± 0.5 ms) in their open dwell time distributions, which had relative weightings of 64 % and 36 %, respectively. However, at higher levels of activation (Po > 0.2) the same RyRs exhibited an additional one or two open time constants of the order of 10 and 100 ms. Thus, out of the five RyRs in this group, three channels showed a total of three exponential components, while another two showed four components. The ATP concentration had no significant effect on the values of the fitted time constants but it did alter their relative weightings (i.e. the relative areas). The long time constant components had combined relative areas (AL) which were proportional to the level of activation and, on average, were ∼0.4 in maximally activated channels (i.e. ∼40 %, see Table 3 and Fig. 9B). AL was proportional to the degree of RyR activation (Po) regardless of whether RyRs were activated by ATP (AL= (0.7 ± 0.08)Po) or inhibited by adenosine (AL= (1.0 ± 0.148)Po). Thus, as seen with mean open times, the effect of adenosine inhibition on AL was effectively the same as a decrease in the ATP concentration.

Table 3.

Summary of parameters from multi-exponential fits to open and closed dwell time probability distributions obtained from RyRs that were near-maximally activated by ATP

Closed dwell times Open dwell times


Exponential component Relative area (%) Time constant (ms) Relative area (%) Time constant (%)
Low Pmax RyRs
 No. 1 25 ± 4 2.4 ± 0.5 72 ± 20 0.7 ± 0.2
 No. 2 48 ± 3 15 ± 5 26 ± 20 2.5 ± 0.4
 No. 3 26 ± 5 66 ± 7
High Pmax RyRs
 No. 1 40 ± 5 0.90 ± 0.13 38 ± 5 1.0 ± 0.14
 No. 2 40 ± 3 4.8 ± 0.7 37 ± 2 6.4 ± 0.8
 No. 3 16 ± 3 25 ± 7 27 ± 5 43 ± 9
 No. 4 10 ± 5 180 ± 12

Data are grouped from five RyRs with medium to high activity (Pmax > 0.2) and another five with low activity (Pmax < 0.2).

Figure 9. Dwell-time probability distributions obtained from RyRs activated by ATP and inhibited by adenosine.

Figure 9

These RyRs showed behaviour representative of the high activity (A and B) and low activity (C and D) RyRs seen in this study. Probability distributions were constructed using the method of Sigworth & Sine (1987) where data were grouped into bins that are equally spaced on a log scale. Using this method, an exponentially decaying distribution is transformed to peaked distribution, where the peak is located at a time equal to its time constant. The continuous curves show examples of the individual exponential components of theoretical curves fitted with the data. A and B, ○, Po= 0.0017. Data were compiled from 123 gating events in an 80 s recording, in the absence of nucleotides. ▴, Po= 0.63. Data compiled from 1910 gating events in a 60 s recording, in the presence of 0.5 mm ATP. There is a considerable increase in the probability of long open events and short closed events. The individual exponential components of an exponential fit to the open data are shown by the continuous curves. •, Po= 0.05. Data compiled from 2920 gating events in a 100 s recording, in the presence of 0.5 mm ATP plus 0.8 mm adenosine. Inhibition increases the probability of long closures and short openings. The open dwell time distribution of the RyR in the presence of ATP and adenosine is very similar to that in the absence of nucleotides. C and D, ○, Po= 0.0084. Data were compiled from 548 gating events in a 60 s recording, in the presence of low (0.1 mm) ATP. ▴, Po= 0.07. Data compiled from 3630 gating events in a 60 s recording, in the presence of 0.5 mm ATP. As with the high activity RyR, there is a considerable increase in the probability of short closed events. However, the open time distribution is unchanged. The individual exponential components in the open and closed data are shown by the continuous curves. •, Po= 0.0089. Data compiled from 670 gating events in an 80 s recording, in the presence of 0.5 mm ATP plus 0.5 mm adenosine. Inhibition increases the probability of long closures but unlike the high activity channel adenosine has no effect on the openings. Once again, the open dwell time distribution of the RyR in the presence of ATP and adenosine is very similar to that in the absence of nucleotide. The parameters of the fitted curves (i.e. the time constants, τ (ms), and relative areas, A, of each exponential component) in each panel are listed in pairs (τ, A): B, 1.0, 0.22; 7.3, 0.44; 41, 0.34; C, 2.2, 0.30; 17, 0.55; 52, 0.15; D, 0.54, 0.76; 2.2, 0.24.

Closed times were mostly described by three exponential components, with time constants over the range 0.5-200 ms depending on their degree of activation (e.g. Fig. 9C and D). RyRs that maximally activated to Po < 0.2 all had very similar closed dwell-time distributions with evenly weighted time constants at 2.4, 15 and 66 ms. RyRs with higher Po had ∼3-fold shorter time constants in their closed dwell-time distributions (see Table 3). The closed dwell time distributions varied in a complex manner with ATP and adenosine and it was not possible to track the individual [ATP] and [adenosine] dependencies of the exponential parameters.

DISCUSSION

This study provides new and detailed information about the regulation of the skeletal muscle RyR by ATP and related nucleotides and presents the first detailed study of adenosine inhibition of RyRs. We describe the mechanism of action of ATP, AMP and adenosine, showing how the distinctive properties can be explained by a scheme based on competitive activation. Then we interpret this scheme in terms of a mechanism in which the overall activation of a RyR depends on nucleotide binding to each of its four subunits. Finally, we discuss the physiological significance of the results, showing how important ATP is to the normal mechanism of excitation-contraction (E-C) coupling in skeletal muscle and how this nucleotide modulation could play a role in muscle fatigue.

General properties of nucleotide regulation of skeletal and cardiac RyRs

The overall characteristics of nucleotide activation of skeletal RyRs measured from our single channel experiments are consistent with those seen previously by studies of 45Ca2+ release from SR vesicles (Morii & Tonomura, 1983; Meissner, 1984; Meissner et al. 1986). The sequence of activation efficacy of ATP, AMP and adenosine is the same as that reported by Meissner (1984). Activation of skeletal RyRs by ATP and its non-hydrolysable analogue AMP-PCP has been reported to have a Ka= 0.3-1 mm with Hill coefficients of ∼2 (Meissner, 1984; Meissner et al. 1986), which are consistent with our findings that Ka= 0.36 mm and that, for the lower activity RyRs, nH∼2. Values of nH that we measured for strongly activated RyRs (nH∼4) have not been previously reported. We report here AMP activation of RyRs with Ka= 1.4 mm, which is similar to that reported by Morii & Tonomura (1983) for Ca2+ release from SR vesicles (Ka= 2 mm), although we found a Hill coefficient of nH∼2 compared to their value of nH∼1, which is an expected consequence of fitting RyRs individually rather than fitting the population response (see Laver et al. 2000b).

Rousseau et al. (1988) found that adenine reduced ATP-induced Ca2+ release from SR vesicles and suggested that adenine and ATP compete for a common binding site on the RyRs. We found that adenosine competes with AMP and ATP for common nucleotide binding sites and we used these competitive interactions to probe the mechanism of nucleotide activation of skeletal RyRs.

Measurements of Ca2+ release from SR vesicles showed that inosine triphosphate (ITP) does not activate skeletal RyRs and, if anything, slightly inhibits them (Meissner, 1984), which potentially could be very important in muscle fatigue. Our single channel measurements, however, show that the physiologically important monophosphate form (IMP) does not directly activate or inhibit RyRs, nor does it interfere with adenine nucleotide activation of the RyRs. Thus, it appears that deamination of the adenosine group to inosine abolishes nucleotide binding to RyRs, rendering the nucleotide functionally inert.

Jona et al. (2001) recently reported the first detailed measurements of ATP activation of rat skeletal RyRs from single channel experiments. They found that ATP in the presence of ∼0.5 μm cytoplasmic Ca2+ activated RyRs to an average Pmax= 0.28, which is similar to our value of Pmax= 0.33 for rabbit RyRs in 1-100 nm Ca2+. Jona et al. (2001) report a biphasic dependence of Po on ATP, the first phase having a Pmax of 0.1 and a Ka of 0.05 mm and the second phase with a Pmax of 0.28 and a Ka of 0.35 mm. We did not observe any feature in the ATP activation of rabbit RyRs that corresponded to the first phase. This was not seen in the activation of individual RyRs or in pooled data, regardless of the method for normalising the data. However, our value for the Ka of ATP activation is close to the value quoted for the second phase of ATP activation of RyRs in rat. The reason for the difference in ATP activation is not clear. It may be due to the species difference or to the different Ca2+ concentrations present during the experiments (cytoplasmic [Ca2+] was 472 nm compared to our 100 nm and luminal [Ca2+] was 50 μm compared to our 1 mm). Another reason may stem from the different experimental protocols used in the two studies. In this study ATP concentrations were varied in pseudorandom order and channels showing irreversible activation during experiments were not included in the analysis. In the study by Jona et al. (2001) ATP concentrations were varied by increments so that activation by ATP or by other factors would not be distinguishable in their data.

Cardiac RyRs are also activated by millimolar concentrations of adenine nucleotides, and adenosine and ADP have also been found to antagonise ATP-induced activation of cardiac RyRs by a mechanism in which adenosine and ADP are relatively weak agonists that compete for ATP sites on the RyR (Kermode et al. 1998; Chan et al. 2000). However, the activation characteristics differ in a number of important respects from those seen in skeletal RyRs. One major difference we see, that is already recognised (Meissner et al. 1988; Kermode et al. 1998; Murayama et al. 2000), is that adenine nucleotides activate skeletal RyRs in the absence of Ca2+ while cardiac RyRs also require Ca2+ to be active (see below). This study also finds several other differences. Firstly, adenosine is a much poorer activator of skeletal RyRs than of cardiac RyRs. Adenosine has been reported to activate cardiac RyRs to a Pmax of ∼0.1 (Chan et al. 2000) or 1 (McGarry & Williams, 1994). In either case, the degree of activation (10- to 40-fold) well exceeds the 2-fold activation seen here with skeletal RyRs. Secondly, nucleotides activate the two RyR isoforms with different apparent affinities. In skeletal muscle the affinities we obtained for ATP, AMP and adenosine were 0.36, 1.4 and 0.06 mm, respectively, compared with 0.22, 3 and 0.2 mm, respectively, for cardiac RyRs (Kermode et al. 1998; Ching et al. 1999; Chan et al. 2000). Thus, the relative affinities of the nucleotide cardiac and skeletal RyRs are quite different. In skeletal RyRs the ratio of the dissociation constants for the binding of ATP and of adenosine to RyRs (KATP/Kad) ∼6 whereas in cardiac RyRs KATP/Kad∼1. In the light of these one would expect adenosine to be a much more potent inhibitor of skeletal RyRs than cardiac RyRs.

The mechanism for ATP activation and adenosine inhibition of RyRs

Here we evolve a model to explain the nucleotide activation and adenosine inhibition of RyRs and interpret this model in terms of the homotetrameric RyR structure. Our data indicate that adenosine inhibits skeletal muscle RyRs by acting as a competitive antagonist to ATP and AMP activation. Adenosine, on its own, is an extremely weak agonist of the RyRs and so in the presence of ATP acts as a channel inhibitor. Furthermore, this inhibition could be partially reversed by increasing the nucleotide concentration (Fig. 1 and 5), which is similar to findings in cardiac RyRs (McGarry & Williams, 1994; Ching et al. 1999; Chan et al. 2000). The Hill coefficients of ≥ 2 (depending on Pmax) for ATP and AMP activation indicate that activation results somehow from the cooperative binding of two or more such molecules to the RyR. More precise information about the mechanism of ATP binding comes from analysis of open and closed dwell-times and of the competition between ATP and adenosine. The [ATP] dependence of τc (N∼2 in eqn (2), see Fig. 7) also indicates that the binding of at least two ATP molecules is needed to cause channel openings. The potency of adenosine inhibition is inversely proportional to the second power of [ATP] (Fig. 5B, 0.5-8 mm ATP), which points to a mechanism whereby the binding of one adenosine molecule can prevent the binding of two activating ATP molecules. Here again is evidence that at least two ATP molecules are needed to activate the channel. These properties are embodied in Scheme 1, which describes the way in which adenosine can act as a competitive agonist to ATP and AMP.

graphic file with name tjp0537-0763-fs1.jpg

The state C indicates the poorly activated states (i.e. Po < 0.01) and OAMP and OATP represent the AMP- and ATP-activated states of the RyR. KATP, KAMP and Kad are the dissociation constants for the binding of ATP, AMP and adenosine to RyRs, respectively. The open probability, based on Scheme 1, is given by eqn (4) in which PAMP and PATP represent the maximal open probabilities attained by AMP and ATP activation, respectively:

graphic file with name tjp0537-0763-m4.jpg (4)

Scheme 1 can account for the nucleotide regulation of RyRs that activate to low levels. It predicts that AMP and ATP activation would have a Hill coefficient of 2 and that nH= 1 for adenosine inhibition. It gives a good fit to the ATP dependence of adenosine inhibition shown in Fig. 5. The best fit to the data was achieved for KATP= 0.4 mm, KAMP= 0.45 mm and Kad= 0.06 mm. (The model fit is not shown but it is very similar to the fit shown for Scheme 2, see below.)

However, Scheme 1 does not explain all our data. It does not account for: (1) nH ∼4 seen in high activity channels, (2) the significant increase in τo when Po exceeds ∼0.2 and (3) the decrease in τo that occurs when adenosine inhibits RyRs with high activity (Scheme 1 predicts that inhibition would occur purely by an increase in τc and that τo would be independent of adenosine concentration). In order to explain these phenomena we need to consider more complex nucleotide regulation mechanisms. Scheme 2 (shown for ATP binding only) is an extension of Scheme 1 in which there is an additional site where ATP, AMP and adenosine molecules can bind competitively to the RyR. The binding of additional ATP (or AMP) can produce an activation state (5) of the RyR that produces relatively long channel openings.

graphic file with name tjp0537-0763-fs2.jpg

In this scheme, m and n represent the total number of ATP and adenosine molecules, respectively, bound to the RyR. KATP2 and Kad2 are the dissociation constants for the binding of ATP and adenosine to 3, respectively. In Scheme 2, low activity RyRs can only adopt 1-3 whereas high activity RyRs can also adopt 4 and 5. We tried fitting this model to the data in Fig. 5 using different combinations of values of m (3 and 4) and n (1 and 2). A satisfactory fit was obtained only when m = 4 and n = 2. In other words, once RyRs have been partly activated by two ATP molecules, the binding of two additional ATPs may activate them further or they may bind one adenosine molecule and remain only partially activated. The combination of m and n (m, n) of (4, 1) gave a fourth order dependence of adenosine inhibition on [ATP] while (3, 1) and (3, 2) predicted dependencies of adenosine inhibition on [ATP] that were too weak to explain the data in Fig. 5B. In order to explain our finding that Ki for adenosine inhibition is the same in high and low activity RyRs it was necessary to have KATP2KATP and Kad2Kad. This model for nucleotide regulation predicts that for RyRs activated to high activity by ATP (or AMP) nH is ∼4 while for low activity RyRs nH is ∼2. It also predicts that adenosine will decrease τo in high activity RyRs via a decrease in the proportion of long channel openings, which is consistent with our findings. However, this model still does not explain the significant difference between KAMP and the Ka for AMP activation of RyRs.

In Scheme 2, 3-5 appear to represent a very similar binding mechanism to 1-3, suggesting that similar nucleotide binding mechanisms may be operating in different parts of the RyR. Since the RyR is a homotetramer it is quite possible that four identical groups of ATP binding sites exist in the RyR. A physical basis for the Scheme 2 mechanism might be as follows. Each subunit of the RyR binds nucleotides according to Scheme 1. When one subunit in the RyR tetramer becomes activated, the channel opens with a mean dwell time of ∼1 ms. If two subunits are simultaneously active then the channel complex enters a more stable open state with longer mean duration. Though not explicitly included in Scheme 2, simultaneous activation of more subunits could further stabilise the open state to create even longer channel openings. The four time constants seen in the open time distributions (∼1, 10, 40 and 200 ms, see Table 3) may correspond to the simultaneous activation of one to four subunits. There is good evidence that this type of mechanism actually occurs in the cyclic nucleotide gated channel (Ruiz & Karpen, 1997, 1999). Stabilisation of channel openings by simultaneous activation of individual subunits would also explain (1) why changes in τo occur via changes in the fraction of events associated with long time constants and (2) why there is a significant increase in τo only when Po exceeds ∼0.2 (Fig. 7C and D). As the activation probability for each subunit exceeds ∼33 %, the probability that two or more subunits are simultaneously active becomes greater than the probability that only one subunit is active. As subunit activation levels cross this threshold during ATP activation or adenosine inhibition the RyR gating switches between being dominated by the longer open states associated with multiple active subunits and by the shorter open states associated with a single active subunit. This model predicts that as RyRs are activated to even higher levels they will tend to do so with larger Hill coefficients and that in the extreme case when RyRs is activated to Pmax∼1 the Hill coefficient could reach a maximum of eight. This would happen because at very high levels of ATP activation it is likely that all four subunits are simultaneously active and hence channel openings would be controlled by cooperative binding at eight ATP sites. However, quantitative validation of this homotetrameric model awaits more direct information on subunit interactions within the RyR complex.

The three features of nucleotide regulation of RyR gating listed above are evidently general properties of RyR gating, given that trends similar to those shown for nucleotide-regulated RyRs in Fig. 7C and D have also been seen in cardiac and skeletal RyRs activated by Ca2+ (D. R. Laver, unpublished observations;Sitsapesan & Williams, 1994; Copello et al. 1997) and by suramin (Sitsapesan & Williams, 1996).

Physiological relevance

The properties of nucleotide regulation of the RyR described here give important insight into the basis of E-C coupling in skeletal muscle. In vertebrate skeletal muscle, the DHPR/voltage sensors in the T-system in some way directly activate the adjacent RyRs, and the influx of extracellular Ca2+ is not required as it is in cardiac muscle (see Introduction). The voltage sensors are able to activate some or all of the RyRs to some degree even when the cytoplasmic [Ca2+] is initially only ∼100 nm or lower. Here, the importance of a key difference in the ATP regulation of skeletal and cardiac RyRs becomes apparent. Cardiac RyRs are not appreciably activated by ATP in the presence of resting levels of cytoplasmic Ca2+ (e.g. ∼100 nm) (Meissner et al. 1988; Kermode et al. 1998) and, though cytoplasmic ATP augments activation, channel opening can be viewed as being primarily gated by cytoplasmic Ca2+, with the influx of extracellular Ca2+ activating the RyRs to some degree and the released Ca2+ triggering further channel activation and Ca2+ release. In contrast, skeletal RyRs are activated appreciably (e.g. Po∼0.3) by millimolar [ATP] when the cytoplasmic [Ca2+] is only at resting levels (∼100 nm) (e.g. Fig. 3 and Meissner et al. 1986, 1988). Thus, the strong activating effect of ATP on the skeletal RyR can explain how the channel can be opened without there being any influx of extracellular Ca2+ to act as a trigger.

Furthermore, comparison of the inhibitory effect of adenosine on ATP activation of the RyR found here (Fig. 1 and 5) with that of voltage sensor-mediated Ca2+ release indicates that the normal E-C coupling mechanism in skeletal muscle absolutely requires up-regulation of the RyR by ATP. Blazev & Lamb (1999a,b) found that cytoplasmic adenosine inhibited voltage sensor control of Ca2+ release in rat skinned muscle fibres, with 0.4 mm adenosine causing some inhibition of release at 2 mm ATP, and 3 mm adenosine virtually eliminating all Ca2+ release at 0.5 mm ATP. In skinned fibres, reducing the cytoplasmic [ATP] to 0.5 mm caused significant inhibition of depolarization-induced Ca2+ release in rat fibres at 3 mm Mg2+ (Blazev & Lamb, 1999a) and an almost 2-fold reduction in amphibian muscle fibres at 1 mm Mg2+ (Owen et al. 1996). In contrast to adenosine, IMP did not interfere with voltage sensor-mediated Ca2+ release (Blazev & Lamb, 1999b). ATP is also necessary for caffeine-induced Ca2+ release and the ability of other nucleotides to interfere is in the following order: adenosine ≫ AMP ≫ IMP (Duke & Steele, 1998; Blazev & Lamb, 1999b). The above results on depolarization-induced and caffeine-induced Ca2+ release in skinned fibres are all in good quantitative agreement with the results found in this study on nucleotide activation and inhibition in single skeletal RyRs. These strongly suggest that (a) the effects of nucleotides observed in the skinned fibre studies were due to actions on the RyRs and (b) that ATP stimulation of the RyRs is essential for normal E-C coupling in skeletal muscle fibres in vivo, with the voltage sensor/DHPRs being unable to activate the RyRs in the absence of such ATP stimulation.

Given the strong stimulatory effect of ATP on the skeletal RyRs at ∼100 nm Ca2+, the question immediately arises as to why the channels are not largely open in a muscle at rest (i.e. with no voltage sensor stimulation of the RyR). This is evidently because the skeletal RyR has an inhibitory site for Ca2+/Mg2+ which has a Ki of ∼0.05-0.1 mm (at physiological ionic strength and [Cl], Laver et al. 1997b; Meissner et al. 1997), with the consequence that in the presence of physiological [Mg2+] (1 mm) the RyR cannot be substantially activated by cytoplasmic Ca2+ and ATP (e.g. maximum Po≤ 0.1, Meissner et al. 1986, 1988; Donoso et al. 2000) unless the SR is overloaded with Ca2+ (Lamb, 2000; Lamb et al. 2001). Thus, as the high peak rate of Ca2+ release occurring in vivo is unlikely to be achieved with such a limited Po (Mejia-Alvarez et al. 1999), the voltage sensor activation of the RyR must overcome or bypass this inhibitory effect of Mg2+ at the Ca2+/Mg2+ site (Lamb & Stephenson, 1991, 1994; Lamb, 2000). Given the above conclusion, that ATP stimulation of the RyRs is required for the voltage sensors to be able to activate the RyRs, and given that such ATP stimulation would be present in a resting fibre, it may be that the voltage sensors could trigger Ca2+ release simply by removing the inhibitory effect of Mg2+ exerted at the Ca2+/Mg2+ inhibitory site, possibly by lowering its affinity for Mg2+ as suggested previously (see Lamb, 2000). The released Ca2+ could then reinforce further activation, increasing Po to close to unity. Mg2+ also binds at the Ca2+-activation site on the RyR (Meissner et al. 1986; Laver et al. 1997a) and if this inhibits RyRs even with ATP present, voltage-sensor activation of the RyRs would have to also decrease or remove this second type of Mg2+ inhibition (Lamb & Stephenson, 1991). Note that in the present experiments where the RyRs are not being stimulated by the voltage sensors, we had to omit Mg2+ in order to measure the activating effects of nucleotides.

Ca2+ release in fatigue

The results here also give insight into how changes in the intracellular milieu occurring in exercise can affect RyR function and Ca2+ release in skeletal muscle. In agreement with Ca2+ release measurements in SR vesicles (Meissner et al. 1986), the results here suggest that activation of the RyR would not be deleteriously affected by a decrease in [ATP] from 8 to 1 mm (Karatzaferi et al. 2001) if it occurred in isolation. However, in a muscle fibre such a decline in [ATP] would be accompanied by an increase in the concentration of the metabolic byproducts of ATP hydrolysis (see Introduction). Accumulation of AMP would be deleterious not only because it would lead to an increase in [ADP] (because of back-inhibition of the reaction 2ADP → AMP + ATP), but also because it would interfere with optimal ATP activation of the RyR, because AMP is a competitive, weak agonist (Fig. 3). (Accumulation of ADP will also be deleterious because it is likely to be a competitive agonist on the RyRs (Kermode et al. 1998). The effect of ADP was not explicitly examined here because the experiments were specifically designed to match the voltage sensor-induced calcium release experiments of Blazev & Lamb (1999a,b).) If AMP were simply further hydrolysed to adenosine, it is clear that the competitive inhibition with ATP at the RyR would be far worse (Figs 1 and 5). In normal skeletal muscle, the problem of adenosine competition with ATP is avoided by rapidly deaminating virtually all AMP to IMP (Sabina et al. 1984; Nagesser et al. 1992, 1993), which has no detectable inhibitory effect on the skeletal RyR (Fig. 6 and Blazev & Lamb, 1999b). The likely importance of this deamination process to normal E-C coupling would explain why myoadenylate deaminase is localised at the junction of the A-I band in mammalian muscle fibres (van Kuppevelt et al. 1994), where the triad junction is also located.

Finally, it is possible that adenosine accumulation does interfere with ATP activation of the RyR in individuals with myoadenylate deaminase deficiency (MDD) and hence contributes to the more rapid onset of muscle fatigue observed in some such individuals (Sabina et al. 1984). Though the average concentration of adenosine measured in the cytoplasm in such cases is relatively low (reaching only ∼50-200 μm with exercise in MDD subjects, cf. < 10 μm in normal subjects), it is quite possible that this is a considerable underestimate of the concentration reached in a restricted space such as the triad junction. (The [adenosine] may also be underestimated owing to measurement problems arising from the rapid resynthesis of adenosine → AMP → ADP → ATP, driven by hydrolysis of the remaining creatine phosphate.) Likewise, the [ATP] in the triad junction may decrease substantially below the minimum measured in the cytoplasm as a whole, particularly as the rate of ATP hydrolysis may be relatively high owing to the high density of ATPases in the terminal cisternae of the SR (Franzini-Armstrong & Jorgensen, 1994) and the T-system. The results of this study indicate that, in such a situation, ATP stimulation of the RyR would be markedly hindered (Fig. 5), thus possibly contributing to reduced Ca2+ release and muscle fatigue (Blazev & Lamb, 1999b).

Acknowledgments

Thanks to Angela Dulhunty, Suzy Pace and Joan Stivala for supplying SR vesicles. This work was supported by the National Health and Medical Research Council of Australia (grant number 9936486).

References

  1. Allen DG, Lännergren J, Westerblad H. Muscle cell function during prolonged activity: cellular mechanisms of fatigue. Experimental Physiology. 1995;80:497–527. doi: 10.1113/expphysiol.1995.sp003864. [DOI] [PubMed] [Google Scholar]
  2. Allen DG, Lännergren J, Westerblad H. The role of ATP in the regulation of intracellular Ca2+ release in single fibres of mouse skeletal muscle. Journal of Physiology. 1997;498:587–600. doi: 10.1113/jphysiol.1997.sp021885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blazev R, Lamb GD. Low [ATP] and elevated [Mg2+] reduce depolarization-induced Ca2+ release in rat skinned skeletal muscle fibres. Journal of Physiology. 1999a;520:203–215. doi: 10.1111/j.1469-7793.1999.00203.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blazev R, Lamb GD. Adenosine inhibits depolarization-induced Ca2+ release in mammalian skeletal muscle. Muscle and Nerve. 1999b;22:1674–1683. doi: 10.1002/(sici)1097-4598(199912)22:12<1674::aid-mus9>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  5. Brooks SP, Storey KB. Bound and determined: a computer program for making buffers of defined ion concentrations. Annals of Biochemistry. 1992;201:119–126. doi: 10.1016/0003-2697(92)90183-8. [DOI] [PubMed] [Google Scholar]
  6. Chan WM, Welch W, Sitsapesan R. Structural factors that determine the ability of adenosine and related compounds to activate the cardiac ryanodine receptor. British Journal of Pharmacology. 2000;130:1618–1626. doi: 10.1038/sj.bjp.0703459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ching LL, Williams AJ, Sitsapesan R. AMP is a partial agonist at the sheep cardiac ryanodine receptor. British Journal of Pharmacology. 1999;127:161–171. doi: 10.1038/sj.bjp.0702491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chu A, Dixon MC, Saito A, Seiler S, Fleischer S. Isolation of sarcoplasmic reticulum fractions referable to longitudinal tubules and junctional terminal cisternae from rabbit skeletal muscle. Methods in Enzymology. 1988;157:36–50. doi: 10.1016/0076-6879(88)57066-0. [DOI] [PubMed] [Google Scholar]
  9. Copello JA, Barg S, Onoue H, Fleischer S. Heterogeneity of Ca2+ gating of skeletal and cardiac ryanodine receptors. Biophysical Journal. 1997;73:141–156. doi: 10.1016/S0006-3495(97)78055-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Donoso P, Aracena P, Hidalgo C. Sulfhydryl oxidation overrides Mg2+ inhibition of calcium-induced calcium release in skeletal muscle triads. Biophysical Journal. 2000;79:279–292. doi: 10.1016/S0006-3495(00)76290-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Duke AM, Steele DS. Effects of caffeine and adenine nucleotides on Ca2+ release by the sarcoplasmic reticulum in saponin-permeabilized frog skeletal muscle fibres. Journal of Physiology. 1998;513:43–53. doi: 10.1111/j.1469-7793.1998.043by.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fitts RH. Cellular mechanisms of muscle fatigue. Physiological Reviews. 1994;74:49–94. doi: 10.1152/physrev.1994.74.1.49. [DOI] [PubMed] [Google Scholar]
  13. Franzini-Armstrong C, Jorgensen AO. Structure and development of E-C coupling units in skeletal muscle. Annual Review of Physiology. 1994;56:509–534. doi: 10.1146/annurev.ph.56.030194.002453. [DOI] [PubMed] [Google Scholar]
  14. Hood DA, Parent G. Metabolic and contractile responses of rat fast-twitch muscle to 10-Hz stimulation. American Journal of Physiology. 1991;260:C832–840. doi: 10.1152/ajpcell.1991.260.4.C832. [DOI] [PubMed] [Google Scholar]
  15. Jona I, Szegedi C, Sarkozi S, Szentesi P, Csernoch L, Kovacs L. Altered inhibition of the rat skeletal ryanodine receptor/calcium release channel by magnesium in the presence of ATP. Pflügers Archiv. 2001;441:729–738. doi: 10.1007/s004240000484. [DOI] [PubMed] [Google Scholar]
  16. Karatzaferi C, de Haan A, Ferguson RA, van Mechelen W, Sargeant AJ. Phosphocreatine and ATP content in human single muscle fibres before and after maximum dynamic exercise. Pflügers Archiv. 2001;442:467–474. doi: 10.1007/s004240100552. [DOI] [PubMed] [Google Scholar]
  17. Kermode H, Williams AJ, Sitsapesan R. The interactions of ATP, ADP, and inorganic phosphate with the sheep cardiac ryanodine receptor. Biophysical Journal. 1998;74:1296–1304. doi: 10.1016/S0006-3495(98)77843-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lamb GD. Excitation-contraction coupling in skeletal muscle: comparisons with cardiac muscle. Clinical and Experimental Pharmacology and Physiology. 2000;27:216–224. doi: 10.1046/j.1440-1681.2000.03224.x. [DOI] [PubMed] [Google Scholar]
  19. Lamb GD, Cellini MA, Stephenson DG. Different Ca2+ releasing actions of caffeine and depolarization in skeletal muscle fibres of the rat. Journal of Physiology. 2001;531:715–728. doi: 10.1111/j.1469-7793.2001.0715h.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lamb GD, Stephenson DG. Effect of Mg2+ on the control of Ca2+ release in skeletal muscle fibres of the toad. Journal of Physiology. 1991;434:507–528. doi: 10.1113/jphysiol.1991.sp018483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lamb GD, Stephenson DG. Effects of intracellular pH and [Mg2+] on excitation-contraction coupling in skeletal muscle fibres of the rat. Journal of Physiology. 1994;478:331–339. doi: 10.1113/jphysiol.1994.sp020253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Laver DR, Baynes TM, Dulhunty AF. Mg2+-inhibition of ryanodine-sensitive Ca2+ channels: evidence for two independent mechanisms. Journal of Membrane Biology. 1997a;156:213–239. doi: 10.1007/s002329900202. [DOI] [PubMed] [Google Scholar]
  23. Laver DR, Eager KR, Taoube L, Lamb GD. Effects of cytoplasmic and luminal pH on Ca2+ release channels from rabbit skeletal muscle. Biophysical Journal. 2000b;78:1835–1851. doi: 10.1016/S0006-3495(00)76733-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Laver DR, Lamb GD. Inactivation of Ca2+ release channels (ryanodine receptors RYR1 and RYR2) with rapid steps in [Ca2+] and voltage. Biophysical Journal. 1998;74:2352–2364. doi: 10.1016/S0006-3495(98)77944-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Laver DR, Lenz GKE, Lamb GD. Regulation of the calcium release channel from skeletal muscle by the nucleotides ATP, AMP, IMP and adenosine. Proceedings of the Australian Physiological and Pharmacological Society. 2000a;31:7. [Google Scholar]
  26. Laver DR, Owen VJ, Junankar PR, Taske NL, Dulhunty AF, Lamb GD. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia. Biophysical Journal. 1997b;73:1913–1924. doi: 10.1016/S0006-3495(97)78222-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Laver DR, Roden LD, Ahern GP, Eager KR, Junankar PR, Dulhunty AF. Cytoplasmic Ca2+ inhibits the ryanodine receptor from cardiac muscle. Journal of Membrane Biology. 1995;147:7–22. doi: 10.1007/BF00235394. [DOI] [PubMed] [Google Scholar]
  28. McGarry SJ, Williams AJ. Adenosine discriminates between the caffeine and adenine nucleotide sites on the sheep cardiac sarcoplasmic reticulum calcium-release channel. Journal of Membrane Biology. 1994;137:169–177. doi: 10.1007/BF00233486. [DOI] [PubMed] [Google Scholar]
  29. Marks PW, Maxfield FR. Preparation of solutions with free calcium concentration in the nanomolar range using 1,2-bis(o-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid. Annals of Biochemistry. 1991;193:61–71. doi: 10.1016/0003-2697(91)90044-t. [DOI] [PubMed] [Google Scholar]
  30. Meissner G. Adenine nucleotide stimulation of Ca2+-induced Ca2+ release in sarcoplasmic reticulum. Journal of Biological Chemistry. 1984;259:2365–2374. [PubMed] [Google Scholar]
  31. Meissner G, Darling E, Eveleth J. Kinetics of rapid Ca2+ release by sarcoplasmic reticulum. Effects of Ca2+, Mg2+, and adenine nucleotides. Biochemistry. 1986;25:236–244. doi: 10.1021/bi00349a033. [DOI] [PubMed] [Google Scholar]
  32. Meissner G, Rios E, Tripathy A, Pasek DA. Regulation of skeletal muscle Ca2+ release channel (ryanodine receptor) by Ca2+ and monovalent cations and anions. Journal of Biological Chemistry. 1997;272:1628–1638. doi: 10.1074/jbc.272.3.1628. [DOI] [PubMed] [Google Scholar]
  33. Meissner G, Rousseau E, Lai FA, Liu QY, Anderson KA. Biochemical characterisation of the Ca2+ release channel of skeletal and cardiac sarcoplasmic reticulum. Molecular and Cellular Biochemistry. 1988;82:59–65. doi: 10.1007/BF00242517. [DOI] [PubMed] [Google Scholar]
  34. Mejia-Alvarez R, Kettlun C, Rios E, Stern M, Fill M. Unitary Ca2+ current through cardiac ryanodine receptor channels under quasi-physiological ionic conditions. Journal of General Physiology. 1999;113:177–186. doi: 10.1085/jgp.113.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Melzer W, Herrmann-Frank A, Lüttgau HC. The role of Ca2+ ions in excitation-contraction coupling of skeletal muscle fibres. Biochimica et Biophysica Acta. 1995;1241:59–116. doi: 10.1016/0304-4157(94)00014-5. [DOI] [PubMed] [Google Scholar]
  36. Miller C, Racker E. Ca2+-induced fusion of fragmented sarcoplasmic reticulum with artificial planar bilayers. Cell. 1976;9:283–300. doi: 10.1007/BF01869673. [DOI] [PubMed] [Google Scholar]
  37. Morii H, Tonomura Y. The gating of a channel for Ca2+-induced Ca2+ release in fragmented sarcoplasmic reticulum. Journal of Biochemistry. 1983;93:1271–1285. doi: 10.1093/oxfordjournals.jbchem.a134261. [DOI] [PubMed] [Google Scholar]
  38. Murayama T, Kurebayashi N, Ogawa Y. Role of Mg2+ in Ca2+-induced Ca2+ release through ryanodine receptors of frog skeletal muscle: modulations by adenine nucleotides and caffeine. Biophysical Journal. 2000;78:1810–1824. doi: 10.1016/S0006-3495(00)76731-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Nagesser AS, van der Laarse WJ, Elzinga G. Metabolic changes with fatigue in different types of single muscle fibres of Xenopus laevis. Journal of Physiology. 1992;448:511–523. doi: 10.1113/jphysiol.1992.sp019054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nagesser AS, van der Laarse WJ, Elzinga G. ATP formation and ATP hydrolysis during fatiguing, intermittent stimulation of different types of single muscle fibres from Xenopus laevis. Journal of Muscle Research and Cell Motility. 1993;14:608–618. doi: 10.1007/BF00141558. [DOI] [PubMed] [Google Scholar]
  41. Owen VJ, Lamb GD, Stephenson DG. Effect of low [ATP] on depolarization-induced Ca2+ release in skeletal muscle fibres of the toad. Journal of Physiology. 1996;493:309–315. doi: 10.1113/jphysiol.1996.sp021385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Rousseau E, Ladine J, Liu Q, Meissner G. Activation of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum by caffeine and related compounds. Archives of Biochemistry and Biophysics. 1988;267:75–86. doi: 10.1016/0003-9861(88)90010-0. [DOI] [PubMed] [Google Scholar]
  43. Ruiz M, Karpen JW. Single cyclic nucleotide-gated channels locked in different ligand-bound states. Nature. 1997;389:389–392. doi: 10.1038/38744. [DOI] [PubMed] [Google Scholar]
  44. Ruiz M, Karpen JW. Opening mechanism of a cyclic nucleotide-gated channel based on analysis of single channels locked in each liganded state. Journal of General Physiology. 1999;113:873–895. doi: 10.1085/jgp.113.6.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sabina RL, Holmes EW. Myoadenylate deaminase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Basis of Inherited Diseases. New York: McGraw-Hill; 1995. pp. 1769–1780. [Google Scholar]
  46. Sabina RL, Swain JL, Olanow CW, Bradley WG, Fishbein WN, Dimauro S, Holmes EW. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. Journal of Clinical Investigation. 1984;73:720–730. doi: 10.1172/JCI111265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sigworth FJ, Sine SM. Data transformations for improved display and fitting of single-channel dwell time histograms. Biophysical Journal. 1987;52:1047–1054. doi: 10.1016/S0006-3495(87)83298-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sitsapesan R, Williams AJ. Gating of the native and purified cardiac SR Ca2+-release channel with monovalent cations as permeant species. Biophysical Journal. 1994;67:1484–1494. doi: 10.1016/S0006-3495(94)80622-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sitsapesan R, Williams AJ. Modification of the conductance and gating properties of ryanodine receptors by suramin. Journal of Membrane Biology. 1996;153:93–103. doi: 10.1007/s002329900113. [DOI] [PubMed] [Google Scholar]
  50. Smith JS, Coronado R, Meissner G. Single channel measurements of the calcium release channel from skeletal muscle sarcoplasmic reticulum. Activation by Ca2+ and ATP and modulation by Mg2+ Journal of General Physiology. 1986;88:573–588. doi: 10.1085/jgp.88.5.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Tanabe T, Beam KG, Adams BA, Niidome T, Numa S. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature. 1990;346:567–568. doi: 10.1038/346567a0. [DOI] [PubMed] [Google Scholar]
  52. van Kuppevelt TH, Veerkamp JH, Fishbein WN, Ogasawara N, Sabina RL. Immunolocalization of AMP-deaminase isozymes in human skeletal muscle and cultured muscle cells: concentration of isoform M at the neuromuscular junction. Journal of Histochemistry and Cytochemistry. 1994;42:861–868. doi: 10.1177/42.7.8014469. [DOI] [PubMed] [Google Scholar]
  53. Westerblad H, Allen DG. Myoplasmic free Mg2+ concentration during repetitive stimulation of single fibres from mouse skeletal muscle. Journal of Physiology. 1992;453:413–434. doi: 10.1113/jphysiol.1992.sp019236. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES